FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)

View source ↗

Summary

FDA approves a supplemental application for NovoLog (insulin aspart) submitted by Novo Nordisk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• NovoLog (insulin aspart)

Snippet

SUPPL AP for NOVOLOG (INSULIN ASPART)